Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19.
NCT04348383
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
156
Enrollment
OTHER
Sponsor class
Conditions
COVID19
Interventions
DRUG:
Defibrotide
DRUG:
Placebo
Sponsor
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia